← All companies
IMUX
Immunic, Inc.
$14.10
+0.11 +0.79%
Key statistics
from XBRL data in SEC filingsMarket cap
$192M
Revenue (TTM)
—
Net income (TTM)
-$104M
EPS (TTM)
$0.81
P/E ratio
17.4
Dividend yield
—
Free cash flow
-$86.0M
Cash
$187M
Total assets
$190M
Gross margin
—
52-week range
$5.06 – $15.84
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Regulation FD disclosure
Jul 14, 2026
8-K
Director or officer change
Jul 6, 2026
8-K
Director or officer change; Shareholder vote results
Jun 29, 2026
8-K
Regulation FD disclosure
May 28, 2026
8-K
Director or officer change; Regulation FD disclosure
May 27, 2026
8-K
Director or officer change; Regulation FD disclosure
May 19, 2026
8-K
Results of operations (earnings release)
May 13, 2026
10-Q
Quarter ended 2026-03-31
May 13, 2026
8-K
Director or officer change; Regulation FD disclosure
Apr 28, 2026
8-K
Modified rights of security holders; Amended charter or bylaws; Other events
Apr 23, 2026
10-K/A
Fiscal year ended 2025-12-31
Apr 22, 2026
8-K
Shareholder vote results; Other events
Apr 14, 2026
8-K
Director or officer change
Apr 10, 2026
8-K
Other events
Apr 1, 2026
8-K
Director or officer change; Regulation FD disclosure
Mar 31, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Results of operations (earnings release)
Feb 26, 2026
8-K
Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events
Feb 13, 2026
8-K
Delisting notice or listing-rule failure
Jan 6, 2026
8-K
Director or officer change
Jan 5, 2026
8-K
Results of operations (earnings release)
Nov 13, 2025
10-Q
Quarter ended 2025-09-30
Nov 13, 2025
8-K
Other events
Sep 25, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Results of operations (earnings release); Other events
Aug 7, 2025
8-K
Director or officer change
Jul 11, 2025
8-K
Delisting notice or listing-rule failure
Jun 27, 2025
8-K
Director or officer change; Shareholder vote results
Jun 4, 2025
8-K
Entered a material agreement; Regulation FD disclosure
May 30, 2025
8-K
Other events
May 28, 2025
10-Q
Quarter ended 2025-03-31
May 15, 2025
8-K
Other events
Apr 30, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure
Apr 9, 2025
10-K
Fiscal year ended 2024-12-31
Mar 31, 2025
8-K
Other events
Feb 20, 2025
8-K
Other events
Jan 13, 2025
8-K
Director or officer change
Dec 18, 2024
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release); Other events
Nov 7, 2024
8-K
Other events
Oct 22, 2024